Latest Share Chat

REMOVE ADS

Hutchmed Share News (HCM)

Hutchmed Information

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes

Get Live Data

168.00 3.25 (1.97%)

Bid:

158.00

Ask:

162.00

Spread: 4.00 (2.532%)

Market Cap: £1.44b

Last checked at -

Intraday Hutchmed Share Chart

REMOVE ADS

Hutchmed News

Hutchmed China completes enrollment for phase three lung cancer trial

(Alliance News) - Hutchmed China Ltd on Wednesday said it has completed patient enrollment of Sanovo, a phase three trial of Orpathys and Tagrisso.

Hutchmed enrols last patient in phase 3 lung cancer trial

(Sharecast News) - Hutchmed China said in an update on Wednesday that it has completed patient enrollment in its phase three 'Sanovo' trial in China t...

Hutchmed China interim profit jumps on joint venture stake disposal

(Alliance News) - Hutchmed China Ltd on Thursday reported a jump in profit during the first half of its current financial year, and forecasts a full-y...

UK earnings, trading statements calendar - next 7 days

Hutchmed to get milestone payment after China drug approval

(Sharecast News) - Hutchmed announced on Monday that China's National Medical Products Administration (NMPA) has approved the new drug application for...

Hutchmed new drug application accepted in China

(Sharecast News) - Hutchmed China and Innovent Biologics announced on Thursday that China's National Medical Products Administration had accepted a ne...

Hutchmed reports progress in late-stage lung cancer trial

(Alliance News) - Hutchmed China Ltd on Monday said its combination therapy for a specific form of advanced lung cancer significantly delayed disease ...

Hutchmed China upbeat on results from lung cancer trial

(Sharecast News) - Hutchmed China reported positive interim results from its phase three 'SACHI' trial on Monday, showing that the combination of savo...